Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$521M |
| 2 |
Nike
NKE
|
+$509M |
| 3 |
Micron Technology
MU
|
+$439M |
| 4 |
Super Micro Computer
SMCI
|
+$435M |
| 5 |
Broadcom
AVGO
|
+$329M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$5.31B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.89B |
| 3 |
Amazon
AMZN
|
+$1.48B |
| 4 |
Microsoft
MSFT
|
+$1.07B |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.38% |
| 2 | Consumer Discretionary | 1.03% |
| 3 | Financials | 0.75% |
| 4 | Healthcare | 0.67% |
| 5 | Communication Services | 0.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11426
PUT
Outset Medical
OM
$79.9M
| $41.2K | ﹤0.01% |
713
-300
| -30% | -$14.7K |
|
11427
Aprea Therapeutics
APRE
$12.3M
| $41.2K | ﹤0.01% |
+10,119
| New | +$52.2K |
|
|
CAPT
11428
PUT
DELISTED
Captivision
CAPT
| $41.1K | ﹤0.01% |
15,400
+1,000
| +7% | +$4.53K |
|
11429
PUT
Porch Group
PRCH
$1.96B
| $41.1K | ﹤0.01% |
27,200
-9,400
| -26% | -$26.2K |
|
11430
CALL
OmniAb
OABI
$699M
| $40.9K | ﹤0.01% |
10,900
-67,800
| -86% | -$309K |
|
|
OMGA
11431
CALL
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $40.6K | ﹤0.01% |
19,600
-14,500
| -43% | -$34.2K |
|
11432
CALL
ProQR Therapeutics
PRQR
$332M
| $40.5K | ﹤0.01% |
24,400
+7,900
| +48% | +$15.3K |
|
|
DAO
11433
PUT
Youdao
DAO
$2.03B
| $40.4K | ﹤0.01% |
+10,300
| New | +$38.7K |
|
|
RJET
11434
CALL
Republic Airways Holdings
RJET
$869M
| $40.4K | ﹤0.01% |
+1,573
| New | +$25.7K |
|
11435
Solitario Resources
XPL
$76M
| $40.1K | ﹤0.01% |
45,299
-78,421
| -63% | -$62K |
|
11436
Evogene
EVGN
$8.58M
| $39.9K | ﹤0.01% |
6,135
+2,885
| +89% | +$20.1K |
|
11437
CALL
GSI Technology
GSIT
$224M
| $39.8K | ﹤0.01% |
15,000
-2,000
| -12% | -$6.52K |
|
|
AIFA
11438
All In FutureTech Alliance Inc
AIFA
$18M
| $39.7K | ﹤0.01% |
+5,216
| New | +$26.3K |
|
11439
Stran & Co
SWAG
$32.6M
| $39.6K | ﹤0.01% |
35,397
+11,538
| +48% | +$13.8K |
|
11440
PLAYSTUDIOS Inc
MYPS
$59.8M
| $39.5K | ﹤0.01% |
19,064
-18,236
| -49% | -$42.9K |
|
11441
Ribbon Communications
RBBN
$363M
| $39.3K | ﹤0.01% |
11,939
-45,358
| -79% | -$138K |
|
11442
CALL
Microvast
MVST
$295M
| $39.1K | ﹤0.01% |
85,000
+5,100
| +6% | +$2.29K |
|
11443
CALL
Fate Therapeutics
FATE
$308M
| $39K | ﹤0.01% |
11,900
-49,200
| -81% | -$215K |
|
11444
CALL
Dakota Gold
DC
$818M
| $39K | ﹤0.01% |
+15,300
| New | +$40.7K |
|
|
NIU
11445
Niu Technologies
NIU
$154M
| $38.9K | ﹤0.01% |
22,340
+2,316
| +12% | +$4.75K |
|
11446
Information Services Group
III
$240M
| $38.7K | ﹤0.01% |
13,169
-16,606
| -56% | -$55.8K |
|
|
RJET
11447
PUT
Republic Airways Holdings
RJET
$869M
| $38.6K | ﹤0.01% |
+1,507
| New | +$24.7K |
|
|
HTT
11448
PUT
High Templar Tech Ltd
HTT
$394M
| $38.6K | ﹤0.01% |
19,500
+9,200
| +89% | +$19.2K |
|
|
LDTC
11449
DELISTED
LeddarTech
LDTC
| $38.5K | ﹤0.01% |
48,338
+19,551
| +68% | +$37.9K |
|
11450
NanoViricides
NNVC
$32.7M
| $38.5K | ﹤0.01% |
+22,356
| New | +$39.8K |
|
Similar funds
Jeff Yass's Q2 2024 Portfolio in Review
As of Q2 2024, Jeff Yass held 13,638 positions worth $537B, down 6.7% from $576B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass withdrew a net $65.7B in Q2 2024, closing 1,726 positions and reducing 5,607 holdings. Its most notable exit was iShares MSCI USA Quality Factor ETF, an estimated $26.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 2.4% of assets, down from 3% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jeff Yass opened a new position in NextEra Energy 7.299% Corporate Units worth $127M.
- Jeff Yass's largest Q2 2024 buy was NextEra Energy 7.299% Corporate Units: 2,575,000 shares worth $127M.
- Jeff Yass added most to Vanguard FTSE Developed Markets ETF in Q2 2024, an estimated $521M increase.
- Jeff Yass's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $5.31B.
- Jeff Yass fully exited iShares MSCI USA Quality Factor ETF in Q2 2024, selling an estimated $26.2M.
- Jeff Yass's ten largest holdings make up 26% of its $537B portfolio in Q2 2024.
- Jeff Yass opened 1,591 new positions and closed 1,726 in Q2 2024.
- Jeff Yass's portfolio value fell 6.7% quarter-over-quarter to $537B.
Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.